Nebu~Flow Overview
- Year Founded
-
2019
- Status
-
Private
- Employees
-
18
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$2.68M
- Investors
-
14
Nebu~Flow General Information
Description
Developer of a novel pulmonary drug-delivery technology designed for patients with respiratory disorders. The company's technology enables efficient delivery of hard-to-nebulize drugs to the lungs, including existing formulations and emerging novel therapeutics such as biologics, nanomedicines and vaccines, enabling medical professionals to cure respiratory diseases.
Contact Information
Website
www.nebuflow.comCorporate Office
- 255 Vincent Street
- Suite F
- Glasgow G2 5QY
- Scotland, United Kingdom
Corporate Office
- 255 Vincent Street
- Suite F
- Glasgow G2 5QY
- Scotland, United Kingdom
Nebu~Flow Timeline
Nebu~Flow Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 01-Jan-2026 | $2.68M | Completed | Generating Revenue | ||
| 8. Seed Round | 02-Apr-2024 | Completed | Generating Revenue | |||
| 7. Grant | 08-Aug-2022 | Completed | Generating Revenue | |||
| 6. Seed Round | 10-May-2022 | Completed | Generating Revenue | |||
| 5. Accelerator/Incubator | 30-Sep-2021 | Completed | Generating Revenue | |||
| 4. Grant | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Grant | 01-Jan-2020 | Completed | Generating Revenue | |||
| 2. Grant | 12-May-2019 | $56.1K | Completed | Generating Revenue | ||
| 1. University Spin-Out | 14-Mar-2019 | Completed | Startup |
Nebu~Flow Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | ||||||||
| A Ordinary | 300,000 | $0.000013 | $2.54 | $2.54 | 1x | $2.54 | 9.51% | |
| A Ordinary | 550,000 | $0.000013 | $2.67 | $2.67 | 1x | $2.67 | 17.43% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Nebu~Flow Comparisons
Industry
Financing
Details
Nebu~Flow Competitors (15)
One of Nebu~Flow’s 15 competitors is Aradigm, a Formerly PE-Backed company based in Hayward, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Aradigm | Formerly PE-Backed | Hayward, CA | ||||
| Enterprise Therapeutics | Venture Capital-Backed | Brighton, United Kingdom | ||||
| Aqualung Therapeutics | Venture Capital-Backed | Tucson, AZ | ||||
| Numerion Labs | Venture Capital-Backed | San Francisco, CA | ||||
| The Zambon Group | Private Debt Financed | Bresso, Italy |
Nebu~Flow Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Nebu~Flow Patents
Nebu~Flow Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202416466-D0 | Nebuliser systems | Pending | 08-Nov-2024 | ||
| WO-2026098941-A1 | Nebuliser systems | Pending | 08-Nov-2024 | ||
| GB-202416461-D0 | Nebulisers and components thereof | Pending | 08-Nov-2024 | ||
| WO-2026098939-A1 | Nebulisers and components thereof | Pending | 08-Nov-2024 | ||
| GB-202410743-D0 | Acoustofluidic device, system and method of operation | Inactive | 23-Jul-2024 | B05B17/0607 |
Nebu~Flow Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Nebu~Flow Investors (14)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Conduit Connect | Impact Investing | Minority | ||
| Social Investment Scotland | Impact Investing | Minority | ||
| Ascension (Private Equity) | Venture Capital | Minority | ||
| Foresight Group | Asset Manager | Minority | ||
| Foresight WAE Technology | Venture Capital | Minority |
Nebu~Flow FAQs
-
When was Nebu~Flow founded?
Nebu~Flow was founded in 2019.
-
Where is Nebu~Flow headquartered?
Nebu~Flow is headquartered in Glasgow, United Kingdom.
-
What is the size of Nebu~Flow?
Nebu~Flow has 18 total employees.
-
What industry is Nebu~Flow in?
Nebu~Flow’s primary industry is Drug Delivery.
-
Is Nebu~Flow a private or public company?
Nebu~Flow is a Private company.
-
What is Nebu~Flow’s current revenue?
The current revenue for Nebu~Flow is .
-
How much funding has Nebu~Flow raised over time?
Nebu~Flow has raised $10.9M.
-
Who are Nebu~Flow’s investors?
Conduit Connect, Social Investment Scotland, Ascension (Private Equity), Foresight Group, and Foresight WAE Technology are 5 of 14 investors who have invested in Nebu~Flow.
-
Who are Nebu~Flow’s competitors?
Aradigm, Enterprise Therapeutics, Aqualung Therapeutics, Numerion Labs, and The Zambon Group are some of the 15 competitors of Nebu~Flow.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
